Revolution Medicines, Inc. (RVMD) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 15.14B |
| Enterprise Value | 14.92B |
| P/E Ratio | -23.64 |
| PEG Ratio | 0.42 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 16.95 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -26.16 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.41 |
| Return On Equity | -0.96 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -16.56M |
| EBITDA | -1.09B |
| Net Income | -1.13B |
| Diluted EPS | -5.95 |
| Total Cash | 3.94B |
| Total Cash/Share | 18.67 |
| Total Debt | 641.93M |
| Total Debt/Equity | 0.25 |
| Current Ratio | 11.38 |
| Book Value Per Share | 12.36 |
| 52-Week Change | 465.96 |
| 52-Week High | 220.34 |
| 52-Week Low | 35.62 |
| Moving Average 50 Days | 187 |
| Moving Average 200 Days | 126.66 |
| Average Volume | 2.55M |
| Shares Outstanding | 212.6M |
| % Held by Institutions | 108.82 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |